Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6299993 | 0.93 | TYMS (0.54) | TYMPTYMS | |
| SCHEMBL6299997 | 0.93 | TYMS (0.54) | TYMPTYMS | |
| SCHEMBL3493524 | 0.90 | TYMP (0.54) | TYMPTYMS | |
| SCHEMBL4170246 | 0.89 | HSP90AA1 (0.45) | TYMPTYMS | |
| SCHEMBL4179824 | 0.88 | TYMP (0.55) | TYMPTYMS | |
| SCHEMBL8326880 | 0.87 | LMNA (0.64) | TYMPTYMS | |
| SCHEMBL1727320 | 0.87 | POLB (0.58) | TYMP | |
| SCHEMBL10446716 | 0.87 | POLB (0.58) | TYMP | |
| SCHEMBL10388602 | 0.87 | TYMP (0.58) | TYMPTYMS | |
| SCHEMBL10692639 | 0.87 | TK1 (0.64) | TYMPTYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090004137-A1 | Uridine Derivatives as Antiviral Drugs Against a Flaviviridae, Especially Hcv | INSTITUTE NATIONAL DE LA SAINTE ET DE LA RECHDERCHE MEDICALE (FR) | 2009-01-01 | — | — | US | disclosed |
| EP-1674104-A1 | Uridine derivatives as antiviral drugs against a flaviviridae, especially HCV | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2006-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090004137-A1 | Uridine Derivatives as Antiviral Drugs Against a Flaviviridae, Especially Hcv | NUDT1, UMPS, UPP1 | TYMP 68/4885TYMS 274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.